title: [Intraperitoneal recombinant gamma interferon (RU 42369) efficacy in ovarian carcinomas. European BRM Study Group].
authors.affiliation: Centre Léon Bérard, Lyon, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Guastalla
authors.forename: E
authors.initials: E
authors.lastname: Pujade-Lauraine
authors.forename: N
authors.initials: N
authors.lastname: Colombo
authors.forename: N
authors.initials: N
authors.lastname: Namer
authors.forename: P
authors.initials: P
authors.lastname: Fumoleau
authors.forename: A
authors.initials: A
authors.lastname: Monnier
authors.forename: M A
authors.initials: MA
authors.lastname: Nooy
authors.forename: G
authors.initials: G
authors.lastname: Falkson
authors.forename: L
authors.initials: L
authors.lastname: Mignot
authors.forename: R
authors.initials: R
authors.lastname: Bugat
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D000328:Adult; D000368:Aged; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007371:Interferon-gamma / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D007371:Interferon-gamma
vernacular_title: Efficacité de l'interféron gamma recombinant (RU 42369) administré par voie intra-péritonéale dans les carcinomes ovariens. European BRM Study Group.